Preparation, characterization and in vitro-targeted delivery of novel Apolipoprotein E-based nanoparticles to C6 glioma with controlled size and loading efficiency

References

• Ishigami M, Swertfeger DK, Granholm NA, Hui DY. Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase. J Biol Chem 1998;273:20156–61
   PubMed Web of Science ®Google Scholar
• Cho HS, Hyman BT, Greenberg SM, Rebeck GW. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation. J Neuropathol Exp Neurol 2001;60:342–9
   PubMed Web of Science ®Google Scholar
• Yokoyama S, Kawai Y, Tajima S, Yamamoto A. Behavior of human apolipoprotein E in aqueous solutions and at interfaces. J Biol Chem 1985;260:16375–82
   PubMed Web of Science ®Google Scholar
• Michaelis K, Hoffmann MM, Dreis S, et al. Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther 2006;317:1246–53
   PubMed Web of Science ®Google Scholar
• Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2001;47:65–81
   PubMed Web of Science ®Google Scholar
• Nikanjam M, Gibbs AR, Hunt CA, et al. Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme. J Control Release 2007;124:163–71
   PubMed Web of Science ®Google Scholar
• Rensen PC, Herijgers N, Netscher MH, et al. Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. J Lipid Res 1997;38:1070–84
   PubMed Web of Science ®Google Scholar
• Rensen PCN, de Vrueh RLA, Kuiper J, et al. Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. Adv Drug Deliv Rev 2001;47:251–76
   PubMed Web of Science ®Google Scholar
• Khumsupan P, Ramirez R, Khumsupan D, Narayanaswami V. Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: a nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid. Biochim Biophys Acta 2011;1808:352–9
   PubMed Web of Science ®Google Scholar
• Michaelis KH, Dreis MM, Herbert S, et al. Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther 2006;317:1246–53
   PubMed Web of Science ®Google Scholar
• Harisa GI, Alanazi FK. Low density lipoprotein bionanoparticles: from cholesterol transport to delivery of anti-cancer drugs. Saudi Pharm J 2014;22:504–15
   PubMed Web of Science ®Google Scholar
• Connelly PW, Maguire GF, Vezina C, et al. Identification of disulfide-linked apolipoprotein species in human lipoproteins. J Lipid Res 1993;34:1717–27
   PubMed Web of Science ®Google Scholar
• Urry DW, Luan CH. Proteins: structure, folding and function. Basel: Birkhäuser; 1997:105–82
   Google Scholar
• Teague SJ. Implications of protein flexibility for drug discovery. Nat Rev Drug Discov 2003;2:527–41
   PubMed Web of Science ®Google Scholar
• Jacobs VL, Valdes PA, Hickey WF, De Leo JA. Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model. ASN Neuro 2011;3:e00063
   PubMed Web of Science ®Google Scholar
• Dorey E, Chang N, Liu QY, et al. Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease. Neurosci Bull 2014;30:317–30
   PubMed Web of Science ®Google Scholar
• Leamon CP, Low PS. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc Natl Acad Sci USA 1991;88:5572–6
   PubMed Web of Science ®Google Scholar
• Weber C, Kreuter J, Langer K. Desolvation process and surface characteristics of HSA-nanoparticles. Int J Pharm 2000;196:197–200
   PubMed Web of Science ®Google Scholar
• Athuluri Divakar SK, Raj Kumar M, Golla K, Anand Kumar K. An efficient targeted drug delivery through apotransferrin loaded nanoparticles. PLoS One 2009;4:e7240
   Google Scholar
• Park YB. Nano-particles of calcium sulfate as a ceramic scaffold for delivery of growth factors to enhance bone regeneration. Buffalo (NY): State University of New York; 2009
   Google Scholar
• Park YB, Mohan K, Al-Sanousi A, et al. Synthesis and characterization of nanocrystalline calcium sulfate for use in osseous regeneration. Biomed Mater 2011;6:055007
   Google Scholar
• Kosasih A, Bowman BJ, Wigent RJ, Ofner CM III. Characterization and in vitro release of methotrexate from gelatin/methotrexate conjugates formed using different preparation variables. Int J Pharm 2000;204:81–9
   PubMed Web of Science ®Google Scholar
• Stockert JC, Blázquez-Castro A, Cañete M, et al. MTT assay for cell viability: intracellular localization of the formazan product is in lipid droplets. Acta Histochem 2012;114:785–96
   PubMed Web of Science ®Google Scholar
• Tahannejad Z, Dayer D, Samie M. The levels of serum alkaline phosphatase and lactate dehydrogenase in hodgkin lymphoma. Iran J Blood Cancer 2012;4:125–8
   Google Scholar
• Strauss BE, Fontes RBV, Lotfi CFP, et al. Retroviral transfer of the p16INK4a cDNA inhibits C6 glioma formation in Wistar rats. Cancer Cell Int 2002;2:1–9
   PubMedGoogle Scholar
• Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30:e36
   PubMed Web of Science ®Google Scholar
• Ren J, Shen S, Wang D, et al. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2. Biomaterials 2012;33:3324–33
   PubMed Web of Science ®Google Scholar
• Myers Benjamin R, Sever N, Chong Yong C, et al. Hedgehog pathway modulation by multiple lipid binding sites on the smoothened effector of signal response. Dev Cell 2013;26:346–57
   PubMed Web of Science ®Google Scholar
• Wilczewska AZ, Niemirowicz K, Markiewicz KH, Car H. Nanoparticles as drug delivery systems. Pharmacol Rep 2012;64:1020–37
   PubMed Web of Science ®Google Scholar
• Kreuter J. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev 2014;71:2–14
   PubMed Web of Science ®Google Scholar
• Wei X, Chen X, Ying M, Lu W. Brain tumor-targeted drug delivery strategies. Acta Pharm Sin B 2014;4:193–201
   PubMed Web of Science ®Google Scholar
• Desai N. Nanoparticle albumin bound (nab) technology: targeting tumors through the endothelial gp60 receptor and SPARC. Nanomedicine Nanotechnol BiolMed 2007;3:339
   Web of Science ®Google Scholar
• Ajouz H, Mukherji D, Shamseddine A. Secondary bile acids: an underrecognized cause of colon cancer. World J Surg Oncol 2014;12:164
   PubMed Web of Science ®Google Scholar
• Saneei P, Esmaillzadeh A. Increased risk of prostate cancer: Vitamin D deficiency or low serum calcium levels? Nutr Cancer 2014;66:914
   PubMed Web of Science ®Google Scholar
• Magrassi L, Bono F, Milanesi G, Butti G. Vitamin D receptor expression in human brain tumors. J Neurosurg Sci 1992;36:27–30
   PubMedGoogle Scholar
• Guillaumond F, Vasseur S. LDL receptor: an open route to feed pancreatic tumor cells. Mol Cell Oncol 2015. [Epub ahead of print]. DOI: 10.1080/23723556.2015.1033586
   PubMed Web of Science ®Google Scholar
• Koyama-Nasu R, Nasu-Nishimura Y, Todo T, et al. The critical role of cyclin D2 in cell cycle progression and tumorigenicity of glioblastoma stem cells. Oncogene 2013;32:3840–5
   PubMed Web of Science ®Google Scholar
• Golestani Eimani B, Sanati MH, Houshmand M, et al. Expression and prognostic significance of bcl-2 and bax in the progression and clinical outcome of transitional bladder cell carcinoma. Cell J 2014;15:356–63
   PubMed Web of Science ®Google Scholar
• Matsumoto H, Wada T, Fukunaga K, et al. Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer. Jpn J Clin Oncol 2004;34:124–30
   PubMed Web of Science ®Google Scholar